Annual EBIT
-$20.25 M
-$437.00 K-2.21%
December 31, 2023
Summary
- As of February 7, 2025, VCNX annual earnings before interest & taxes is -$20.25 million, with the most recent change of -$437.00 thousand (-2.21%) on December 31, 2023.
- During the last 3 years, VCNX annual EBIT has risen by +$8.11 million (+28.60%).
- VCNX annual EBIT is now -84.88% below its all-time high of -$10.95 million, reached on December 31, 2016.
Performance
VCNX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.73 M
-$101.00 K-1.79%
September 30, 2024
Summary
- As of February 7, 2025, VCNX quarterly earnings before interest & taxes is -$5.73 million, with the most recent change of -$101.00 thousand (-1.79%) on September 30, 2024.
- Over the past year, VCNX quarterly EBIT has dropped by -$1.86 million (-48.15%).
- VCNX quarterly EBIT is now -153.97% below its all-time high of -$2.26 million, reached on December 31, 2017.
Performance
VCNX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$18.55 M
-$820.00 K-4.63%
September 30, 2024
Summary
- As of February 7, 2025, VCNX TTM earnings before interest & taxes is -$18.55 million, with the most recent change of -$820.00 thousand (-4.63%) on September 30, 2024.
- Over the past year, VCNX TTM EBIT has increased by +$609.00 thousand (+3.18%).
- VCNX TTM EBIT is now -240.66% below its all-time high of -$5.45 million, reached on March 31, 2017.
Performance
VCNX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VCNX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.2% | -48.1% | +3.2% |
| 3 y3 years | +28.6% | -15.5% | +8.1% |
| 5 y5 years | +30.5% | -15.5% | +8.1% |
VCNX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +6.1% | -72.8% | +18.8% | -4.6% | +15.7% |
| 5 y | 5-year | -2.2% | +36.5% | -72.8% | +33.4% | -4.6% | +42.0% |
| alltime | all time | -84.9% | +36.5% | -154.0% | +37.3% | -240.7% | +45.6% |
Vaccinex EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.73 M(+1.8%) | -$18.55 M(+4.6%) |
| Jun 2024 | - | -$5.63 M(+45.5%) | -$17.73 M(-7.5%) |
| Mar 2024 | - | -$3.87 M(+16.6%) | -$19.16 M(-5.4%) |
| Dec 2023 | -$20.25 M(+2.2%) | -$3.32 M(-32.5%) | -$20.25 M(-8.0%) |
| Sep 2023 | - | -$4.91 M(-30.4%) | -$22.01 M(+0.7%) |
| Jun 2023 | - | -$7.06 M(+42.3%) | -$21.86 M(+8.3%) |
| Mar 2023 | - | -$4.96 M(-2.3%) | -$20.18 M(+1.9%) |
| Dec 2022 | -$19.81 M(-8.1%) | -$5.08 M(+6.7%) | -$19.81 M(+2.2%) |
| Sep 2022 | - | -$4.76 M(-11.6%) | -$19.38 M(-1.6%) |
| Jun 2022 | - | -$5.38 M(+17.2%) | -$19.69 M(-1.2%) |
| Mar 2022 | - | -$4.59 M(-1.1%) | -$19.92 M(-7.6%) |
| Dec 2021 | -$21.57 M(-23.9%) | -$4.65 M(-8.2%) | -$21.57 M(-6.3%) |
| Sep 2021 | - | -$5.06 M(-9.9%) | -$23.03 M(-13.3%) |
| Jun 2021 | - | -$5.62 M(-10.0%) | -$26.57 M(-3.2%) |
| Mar 2021 | - | -$6.24 M(+2.2%) | -$27.45 M(-3.2%) |
| Dec 2020 | -$28.36 M | -$6.11 M(-29.0%) | -$28.36 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$8.61 M(+32.4%) | -$28.58 M(+3.5%) |
| Jun 2020 | - | -$6.50 M(-9.1%) | -$27.62 M(-7.9%) |
| Mar 2020 | - | -$7.15 M(+13.0%) | -$29.98 M(-6.2%) |
| Dec 2019 | -$31.86 M(+9.4%) | -$6.33 M(-17.2%) | -$31.97 M(-6.2%) |
| Sep 2019 | - | -$7.64 M(-13.7%) | -$34.09 M(+3.3%) |
| Jun 2019 | - | -$8.86 M(-3.1%) | -$33.00 M(+7.6%) |
| Mar 2019 | - | -$9.14 M(+8.2%) | -$30.67 M(+5.3%) |
| Dec 2018 | -$29.13 M(+67.4%) | -$8.45 M(+28.9%) | -$29.13 M(+27.0%) |
| Sep 2018 | - | -$6.55 M(+0.4%) | -$22.93 M(+6.4%) |
| Jun 2018 | - | -$6.53 M(-14.1%) | -$21.55 M(+10.2%) |
| Mar 2018 | - | -$7.59 M(+236.5%) | -$19.55 M(+12.4%) |
| Dec 2017 | -$17.40 M(+58.9%) | -$2.26 M(-56.4%) | -$17.40 M(+14.9%) |
| Sep 2017 | - | -$5.17 M(+14.4%) | -$15.14 M(+51.9%) |
| Jun 2017 | - | -$4.52 M(-16.9%) | -$9.97 M(+83.1%) |
| Mar 2017 | - | -$5.45 M | -$5.45 M |
| Dec 2016 | -$10.95 M | - | - |
FAQ
- What is Vaccinex annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vaccinex?
- What is Vaccinex annual EBIT year-on-year change?
- What is Vaccinex quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vaccinex?
- What is Vaccinex quarterly EBIT year-on-year change?
- What is Vaccinex TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vaccinex?
- What is Vaccinex TTM EBIT year-on-year change?
What is Vaccinex annual earnings before interest & taxes?
The current annual EBIT of VCNX is -$20.25 M
What is the all time high annual EBIT for Vaccinex?
Vaccinex all-time high annual earnings before interest & taxes is -$10.95 M
What is Vaccinex annual EBIT year-on-year change?
Over the past year, VCNX annual earnings before interest & taxes has changed by -$437.00 K (-2.21%)
What is Vaccinex quarterly earnings before interest & taxes?
The current quarterly EBIT of VCNX is -$5.73 M
What is the all time high quarterly EBIT for Vaccinex?
Vaccinex all-time high quarterly earnings before interest & taxes is -$2.26 M
What is Vaccinex quarterly EBIT year-on-year change?
Over the past year, VCNX quarterly earnings before interest & taxes has changed by -$1.86 M (-48.15%)
What is Vaccinex TTM earnings before interest & taxes?
The current TTM EBIT of VCNX is -$18.55 M
What is the all time high TTM EBIT for Vaccinex?
Vaccinex all-time high TTM earnings before interest & taxes is -$5.45 M
What is Vaccinex TTM EBIT year-on-year change?
Over the past year, VCNX TTM earnings before interest & taxes has changed by +$609.00 K (+3.18%)